Jiawei Liu
Analista de Capital Privado en Vivo Capital LLC .
Origen de la red de primer grado Jiawei Liu.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Vivo Capital LLC
 Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California.
50
| Private Company | Investment Managers | 50 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Jiawei Liu a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
| Rochester Christian University | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| Fudan University | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
Shanghai Rarestone Health Tech Group Co. Ltd.
 Shanghai Rarestone Health Tech Group Co. Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Rarestone Health Tech Group Co. Ltd. is a Chinese company that focuses on rare disease therapy and self-management information through internet information. The company is based in Huangpu, China. The company also operates and promote medical devices and communication platforms. The CEO of the company is Shawn Xiang. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder | |
| Vivo Co-Invest (S) LP | Director/Board Member Director/Board Member Director/Board Member | ||
Semnur Pharmaceuticals, Inc.
 Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
| University of California, Berkeley | College/University | Doctorate Degree Masters Business Admin Undergraduate Degree | |
MacuLogix, Inc.
 MacuLogix, Inc. Medical/Nursing ServicesHealth Services MacuLogix, Inc. engages in the early detection and tracking of retinal diseases. Its AdaptDx is the first practical measurement tool for dark adaptation which provides doctors with an easy-to-use functional test similar to routine perimetry testing for glaucoma. The company also provides macular degeneration services. The company was founded by John G. Edwards and Gregory R. Jackson in 2004 and is headquartered in Harrisburg, PA. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| SAGENT PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| TOT BIOPHARM INTERNATIONAL COMPANY LIMITED | Pharmaceuticals: Major | Director/Board Member Chairman | |
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Pharmaceuticals: Major | Founder Chief Executive Officer | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin | |
| INNOCARE PHARMA LIMITED | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Columbia University College of Physicians & Surgeons | College/University | Doctorate Degree Doctorate Degree | |
VISEN Pharmaceuticals
 VISEN Pharmaceuticals BiotechnologyHealth Technology VISEN Pharmaceuticals operates as a biopharmaceutical company. It focuses on developing therapies and patient-centric care on endocrine diseases. The firm operates a segment which is developing and commercializing paradigm-shifting endocrine therapies in Greater China. The company was founded on November 1, 2018 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member Director/Board Member | |
VISEN Pharmaceuticals (Shanghai) Co., Ltd.
 VISEN Pharmaceuticals (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology VISEN Pharmaceuticals (Shanghai) Co., Ltd. is a Chinese pharmaceutical company that focuses on the development of products and technology for endocrine diseases. The company is based in Shanghai, China, and the CEO of the company is An Bang Lu. The company has developed a product called Long Pei, which is the first American FDA-approved growth hormone that can be released within a week to deliver growth hormone. VISEN Pharmaceuticals has also entered into a strategic cooperation agreement with Peking University Clinical Research Institute to carry out clinical research on thyroid dysfunction. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Surgical Specialties Corp.
 Surgical Specialties Corp. Medical SpecialtiesHealth Technology Surgical Specialties Corp. manufactures medical products. It specializes in designing and manufacturing of surgical knives and wound closure products. The firm offers suture needles, sutures, microsurgical cutting instruments, eye garters, and ophthalmic cannulas. The company is headquartered in Westwood, MA. | Medical Specialties | Chairman Chief Executive Officer | |
Medeor Therapeutics, Inc.
 Medeor Therapeutics, Inc. Medical/Nursing ServicesHealth Services Medeor Therapeutics, Inc. engages in medical industry. It provides services which are dedicated to the discovery, development, and commercialization of transformative and personalized cellular therapeutics. The company was founded by Samuel Strober, Edgar Engleman, Robert Lowsky, and Chih Ping in 2012 and is headquartered in South San Francisco, CA. | Medical/Nursing Services | Founder Director/Board Member | |
Peking University
 Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Undergraduate Degree Graduate Degree | |
| Sichuan University | College/University | Undergraduate Degree Undergraduate Degree | |
| NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO.,LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| CRINETICS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Tsinghua University | College/University | Undergraduate Degree Graduate Degree | |
| MORGAN STANLEY | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
| SOLENO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BOLT BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
SCILEX Pharmaceuticals, Inc.
 SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Crown Bioscience, Inc.
 Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Miscellaneous Commercial Services | Director/Board Member | |
ADARx Pharmaceuticals, Inc.
 ADARx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services ADARx Pharmaceuticals, Inc. operates as RNA base-editing company. The company is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Founder | |
| Jian Rui Bao | Director/Board Member | ||
German Medical Technology Co., Ltd.
 German Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology German Medical Technology Co., Ltd. develops, manufactures, and sells disposable and implantable medical devices. | Medical Specialties | Director/Board Member | |
RiboX Therapeutics, Inc.
 RiboX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology RiboX Therapeutics, Inc. engages in the development of fully engineered circular RNA therapeutics. The private company is based in Shanghai, China. | Pharmaceuticals: Major | Director/Board Member | |
Zenas Pharma, Inc.
 Zenas Pharma, Inc. BiotechnologyHealth Technology Zenas Pharma, Inc. is an American pharmaceutical company that is focused on developing a portfolio of first- and autoimmune therapeutics to address areas of high unmet medical need. The company is located in the US. The company's lead product candidate, obexelimab (zb012), is a novel bifunctional antibody with first-in-class potential that inhibits B-cell lineages that express CD19. | Biotechnology | Director/Board Member | |
| Tarsus China Ltd. | Director/Board Member | ||
Upstream Bio, Inc.
 Upstream Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Upstream Bio, Inc. is a clinical-stage biopharmaceutical company based in Waltham, MA, USA. The American company's lead program, upb-101, is a monoclonal antibody that inhibits the TSLP receptor, a validated target that affects various immune cells involved in common and rare diseases. Upstream Bio is leveraging its diverse roots and substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones. The company was founded by Eran Perry and Earn Perry, and Samantha Truex has been the CEO since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
| NEW FRONTIER HEALTH CORPORATION | Packaged Software | Director/Board Member | |
Shanghai ShouTi Biotechnology Co., Ltd.
 Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | Biotechnology | Director/Board Member | |
Perkins Coie Ventures
 Perkins Coie Ventures Investment ManagersFinance Perkins Coie Ventures (Perkins Coie Ventures) is a venture capital subsidiary of Perkins Coie LLP founded in 1996. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
| PASSAGE BIO, INC. | Biotechnology | Director/Board Member | |
| CHINA ANIMAL HEALTHCARE LTD. | Pharmaceuticals: Major | Director/Board Member | |
Labcyte, Inc.
 Labcyte, Inc. Medical/Nursing ServicesHealth Services Labcyte, Inc. operates as a biotechnology tools company that manufactures and markets echo liquid handling systems. It offers liquid handling, automation and consumables. The company was founded by Richard Nathan Ellson and Mark D. Fischer-Colbrie and A. Mark Bramwell in October 2003 and is headquartered in Sunnyvale, CA. | Medical/Nursing Services | Corporate Officer/Principal | |
The Blackstone Group
 The Blackstone Group Investment ManagersFinance Part of Blackstone, Inc., The Blackstone Group enables leading energy companies to build enterprises at scale that can deliver clean, reliable and affordable energy to help meet needs. The company is based in Beijing, China. The Chinese company invests in companies shaping the future, helping emerging leaders become champions through the power of the Blackstone platform. | Investment Managers | Corporate Officer/Principal |
Estadísticas
Internacional
| Estados Unidos | 32 |
| China | 14 |
| Hong-Kong | 3 |
| Islas Caimán | 3 |
| Bermudas | 2 |
Sectorial
| Health Technology | 27 |
| Consumer Services | 11 |
| Health Services | 4 |
| Finance | 4 |
| Commercial Services | 4 |
Operativa
| Director/Board Member | 185 |
| Private Equity Investor | 46 |
| Corporate Officer/Principal | 41 |
| Independent Dir/Board Member | 38 |
| Undergraduate Degree | 33 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Jack Nielsen | 38 |
| Mahendra Shah | 35 |
| Chen-Ming Yu | 33 |
| Edgar Engleman | 29 |
| Hong Bo Lu | 28 |
| Frank Kung | 22 |
| Gaurav Aggarwal | 21 |
| Scott Whitcup | 18 |
| Shan Fu | 17 |
| Mitchell Mutz | 16 |
| Joseph Siletto | 12 |
| Sean Lo | 9 |
| Yuh-Geng Tsay | 8 |
| Dan Dan Dong | 8 |
| John Massad | 6 |
- Bolsa de valores
- Insiders
- Jiawei Liu
- Conexiones Empresas
